Covid 19: India is the new global hotspot; Oxford vaccine sees a hurdle
India has emerged as the global hotspot for Coronavirus infections with the number of cases crossing 4 million. The senior experts are not denying the possibility of a second wave of infections even as the country could not swim through the first wave.
India surpassed Brazil to become the second-most Covid 19 infected country after the US. The country has been registering more than 70,000 cases per day for the past few days. Despite taking precautions suggested by the government, the numbers continue to rise. Reopening of the economy in the fourth phase of lockdown has not helped either.
Pune is the city with the highest number of cases after Mumbai. Maharashtra continues to register the highest number of cases, being the state with maximum infections. Tamil Nadu, Andhra, Karnataka, Delhi and Uttar Pradesh too continue to register rise in the cases. Despite many relaxations in the fourth phase of the lockdown, schools and colleges would not reopen. However, many national level exams continue to take place.
Oxford vaccine hurdle
The hopes of vaccines developed by the Oxford University and AstraZeneca came to a standstill when a participant had a suspected adverse reaction in the UK.
AstraZeneca described it as a “routine” pause in the case of “an unexplained illness”.
The outcome of vaccine trials is being closely watched around the world. The AstraZeneca-Oxford University vaccine was seen as a strong contender among dozens being developed globally.
The participant had inflammatory syndrome that affects the spinal cord and can be caused by viral infections.